Expression of survivin correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma of the lung

被引:123
作者
Ikehara, M
Oshita, F
Kameda, Y
Ito, H
Ohgane, N
Suzuki, R
Saito, H
Yamada, K
Noda, K
Mitsuda, A
机构
[1] Kanagawa Canc Ctr, Dept Thorac Oncol, Asahi Ku, Yokohama, Kanagawa 2410815, Japan
[2] Kanagawa Canc Ctr, Dept Pathol, Asahi Ku, Yokohama, Kanagawa 2410815, Japan
关键词
survivin; vessel invasion; non-small cell lung cancer;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
The purpose of this study was to investigate the possible association between expression of survivin, pathological findings in the tumor and survival in patients with small adenocarcinoma of the lung. Seventy-nine patients with resected tumors <2 cm in diameter were entered into the study. There were 33 males and 46 females, with a median age of 64 years (range 26-83 years). The pathological stage of the tumors was recorded as stage I, II, III and IV in 72, one, five and one case, respectively. Each patient underwent curative surgical resection for lung, cancer between July 1992 and November 1999. The resected tumors were subjected to immunostaining for survivin. Thirty-eight patients had tumors with ≤10% survivin-positive cells and 41 patients had tumors with >10% survivin-positive cells. When survivin expression and pathological findings in the resected tumors were analyzed, the frequency of venous invasion was significantly higher in the survivin-positive group (36.6% vs. 13.2%; p=0.0167). In contrast, the overall survival of survivin-positive patients (n=41) was significantly worse than that of individuals whose tumors were negative for survivin expression (n=38; log-rank test, p=0.014; Wilcoxon test, p=0.021). It can be concluded that the expression of survivin in tumor cells is a factor of poor prognosis in patients with small adenocarcinoma of the lung.
引用
收藏
页码:835 / 838
页数:4
相关论文
共 14 条
[1]
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma [J].
Ambrosini, G ;
Adida, C ;
Altieri, DC .
NATURE MEDICINE, 1997, 3 (08) :917-921
[2]
Cohen O, 1999, J CELL BIOL, V146, P141
[3]
Fukuse T, 2000, CANCER RES, V60, P242
[4]
Herbst RS, 2000, CLIN CANCER RES, V6, P790
[5]
Retinoic acid receptor-beta as a prognostic indicator in stage I non-small-cell lung cancer [J].
Khuri, FR ;
Lotan, R ;
Kemp, BL ;
Lippman, SM ;
Wu, H ;
Feng, L ;
Lee, JJ ;
Cooksley, CS ;
Parr, B ;
Chang, E ;
Walsh, GL ;
Lee, JS ;
Hong, WK ;
Xu, XC .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (15) :2798-2804
[6]
A novel anti-apoptosis gene:: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers [J].
Monzó, M ;
Rosell, R ;
Felip, E ;
Astudillo, J ;
Sánchez, JJ ;
Maestre, J ;
Martín, C ;
Font, A ;
Barnadas, A ;
Abad, A .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) :2100-2104
[7]
NOGUCHI M, 1995, CANCER-AM CANCER SOC, V75, P2844, DOI 10.1002/1097-0142(19950615)75:12<2844::AID-CNCR2820751209>3.0.CO
[8]
2-#
[9]
Tumor angiogenesis and recurrence in stage I non-small cell lung cancer [J].
Ohta, Y ;
Tomita, Y ;
Oda, M ;
Watanabe, S ;
Murakami, S ;
Watanabe, Y .
ANNALS OF THORACIC SURGERY, 1999, 68 (03) :1034-1038
[10]
Oshita F, 1999, CLIN CANCER RES, V5, P617